Denby William C

Avg. Two Year Performance

(26%) Avg. Purchase Return
(12%) Compound
7% Avg. Sale Return
4% Compound
1 Mo3 Mo6 Mo1 Yr2 Yr
Average Purchase Return(15%)(26%)(3%)(45%)(26%)
Purchase Success Rate0 of 20 of 21 of 20 of 20 of 2
Average Sale Return(6%)(11%)(3%)5%7%
Sale Success Rate10 of 2310 of 2311 of 2315 of 2316 of 23

Santarus Inc.

Drugs » Drug Manufacturers - Other

Sr. VP, Commercial Operations:

Holdings: 0 shares

Sentiment

Insider Trading Sentiment: Hold

Avg. Two Year Performance

No purchase track record
No sale track record

Last Three Months:

0 Net Amount
Buy:0--
Sell:0--

Dmk Pharmaceuticals Corp

Drugs » Biotechnology

Director:

Holdings: 108.75K shares

Sentiment

Insider Trading Sentiment: Hold

Avg. Two Year Performance

No purchase track record
No sale track record

Last Three Months:

0 Net Amount
Buy:0--
Sell:0--